iBio, Inc. (IBIO)
1.125
+0.02
(+1.35%)
USD |
NASDAQ |
Oct 02, 16:00
1.09
-0.04
(-3.11%)
After-Hours: 20:00
iBio Price : 1.125 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.12 | 1.15 | 1.065 | 1.125 | 534395.0 |
| Oct 01, 2026 | 1.18 | 1.210 | 1.10 | 1.11 | 341275.0 |
| Sep 30, 2026 | 1.19 | 1.22 | 1.17 | 1.18 | 229671.0 |
| Sep 29, 2026 | 1.195 | 1.195 | 1.16 | 1.17 | 236488.0 |
| Sep 28, 2026 | 1.19 | 1.19 | 1.15 | 1.17 | 297211.0 |
| Sep 25, 2026 | 1.23 | 1.24 | 1.15 | 1.19 | 621018.0 |
| Sep 24, 2026 | 1.25 | 1.25 | 1.19 | 1.20 | 378017.0 |
| Sep 23, 2026 | 1.32 | 1.348 | 1.24 | 1.245 | 363824.0 |
| Sep 22, 2026 | 1.28 | 1.370 | 1.235 | 1.33 | 2.093M |
| Sep 21, 2026 | 1.29 | 1.305 | 1.26 | 1.26 | 389438.0 |
| Sep 18, 2026 | 1.26 | 1.300 | 1.24 | 1.28 | 445362.0 |
| Sep 17, 2026 | 1.25 | 1.310 | 1.21 | 1.25 | 2.090M |
| Sep 16, 2026 | 1.19 | 1.20 | 1.17 | 1.18 | 407174.0 |
| Sep 15, 2026 | 1.20 | 1.22 | 1.17 | 1.19 | 375779.0 |
| Sep 14, 2026 | 1.23 | 1.23 | 1.20 | 1.20 | 325262.0 |
| Sep 11, 2026 | 1.24 | 1.24 | 1.20 | 1.205 | 184893.0 |
| Sep 10, 2026 | 1.26 | 1.26 | 1.22 | 1.225 | 309089.0 |
| Sep 09, 2026 | 1.30 | 1.30 | 1.25 | 1.26 | 410929.0 |
| Sep 08, 2026 | 1.31 | 1.32 | 1.28 | 1.30 | 191783.0 |
| Sep 04, 2026 | 1.29 | 1.33 | 1.28 | 1.31 | 265444.0 |
| Sep 03, 2026 | 1.32 | 1.348 | 1.29 | 1.30 | 354195.0 |
| Sep 02, 2026 | 1.26 | 1.335 | 1.26 | 1.31 | 311034.0 |
| Sep 01, 2026 | 1.27 | 1.30 | 1.210 | 1.26 | 2.234M |
| Aug 31, 2026 | 1.37 | 1.37 | 1.25 | 1.27 | 875831.0 |
| Aug 28, 2026 | 1.42 | 1.42 | 1.34 | 1.36 | 521249.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| PS Ratio | 920.85 |
| Price to Book Value | 0.7311 |
| Earnings Yield | -40.32% |
| Market Cap | 62.66M |